✦ LIBER ✦

Safety and efficacy of peginterferon-α2a plus ribavirin treatment in renal transplant recipients with chronic hepatitis C

✍ Scribed by Sanai, Faisal M.; Mousa, Dujana; Al-Mdani, Abdallah; Al-Shoail, Ghada; Al-Ashgar, Hamad; Al Meshari, Khalid; Al-Qahtani, Ahmed; Saadeh, Mayssa; Bzeizi, Khalid I.; Aleid, Hassan

Book ID: 119963948
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 762 KB
Volume: 58
Category: Article
ISSN: 0168-8278
DOI: 10.1016/j.jhep.2013.02.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

782 CHRONIC HEPATITIS C GENOTYPE 4: EFFI

782 CHRONIC HEPATITIS C GENOTYPE 4: EFFICACY AND SAFETY OF THE TREATMENT WITH PEGINTERFERON ALFA-2A PLUS RIBAVIRIN

✍ M. Diago; J. Boadas; R. Planas; R. Sola; J.A. del Olmo; J. Crespo; J.C. Erdozaín 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Peginterferon-Α_2B plus ribavirin is mor

Peginterferon-Α_2B plus ribavirin is more effective than peginterferon-Α_2A plus ribavirin in menopausal women with chronic hepatitis C

✍ E. Villa; C. Cammà; A. Di Leo; A. Karampatou; M. Enea; S. Gitto; V. Bernabucci; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

Randomized trial of peginterferon α-2a p

Randomized trial of peginterferon α-2a plus ribavirin versus peginterferon α-2b plus ribavirin for chronic hepatitis C in Japanese patients

✍ Shiho Miyase, Katsuki Haraoka, Yoshihiro Ouchida, Yuko Morishita, Shigetoshi Fuj 📂 Article 📅 2012 🏛 Springer Japan 🌐 English ⚖ 227 KB

Efficacy and safety of peginterferon alp

Efficacy and safety of peginterferon alpha-2a/ribavirin in treatment-naive Cameroonian patients with chronic hepatitis C

✍ Richard Njouom; Michèle Tagni Sartre; Isabelle Timba; Eric Nerrienet; Patrice Tc 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 1 views

## Abstract Data were examined from a day‐to‐day clinical practice in Yaounde, Cameroon to evaluate the efficacy and safety of peginterferon alfa‐2a and ribavirin in treatment‐naive Cameroonian patients with chronic hepatitis C. Ninety adults with chronic hepatitis C (mean age, 53 ± 8 years; 79% ma

Safety and efficacy of peginterferon plu

Safety and efficacy of peginterferon plus ribavirin in patients with chronic hepatitis C and bridging fibrosis or cirrhosis

✍ F. Marrache; Y. Consigny; M. P. Ripault; D. Cazals-Hatem; M. Martinot; N. Boyer; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

Safety and efficacy of peginterferon alp

Safety and efficacy of peginterferon alpha plus ribavirin in patients with chronic hepatitis C and coexisting heart disease

✍ Emanuele Durante-Mangoni; Domenico Iossa; Daniela Pinto; Lucia De Vincentiis; En 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 139 KB